Intelliseq S.A.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-12-31
Share capital
3,032,404.50 PLN
Activity description

Intelliseq is a company that provides a cloud-based platform for the analysis of Next-Generation Sequencing (NGS) data and clinical interpretation. Their services include automated genomic analysis and reporting through products like iFlow™ and GeneSpect™ Reporters, which cover various medical conditions such as hereditary cancers and cardiovascular diseases. The platform is designed for ease of use, allowing users to perform analyses without needing extensive expertise.

Registered address
ul. Stanisława Konarskiego 42/13, 30-046 Kraków, Poland
Email
Electronic delivery address
AE:PL-66195-56580-IIBFF-14

Financials

Revenue history (in k)

Filing timeliness

2 of 5 financial statements were filed late (the longest delay 81 days for 2021). 4 of 5 audited by a statutory auditor.

  • 202501/10/2026
  • 202426/06/2025
  • 202305/07/2024
  • 202204/07/2023
  • 202104/10/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 38%
City · Kraków8,839 / 16,158
Top 55%
Voivodeship · Małopolskie16,249 / 27,734
Top 59%
Country · Poland176,429 / 297,266
Top 59%

Results vs industry

Revenue
This companyUSD 156.55kMedianUSD 56.72kAverageUSD 2.72m
Net profit
This companyUSD -968.45kMedianUSD -1.27kAverageUSD -93.01k
Operating costs
This companyUSD 1.11mMedianUSD 66.48kAverageUSD 2.68m
Assets
This companyUSD 2.74mMedianUSD 134.71kAverageUSD 3.04m

Offer

  • Genomic data analysis
  • Genetic variant interpretation
  • Genetic results reporting
  • Bioinformatics platform
  • Pharmacogenomic analysis
  • Hereditary disease diagnostics
Certifications: ISO 13485

Websites

Authorized Representatives

Klaudia Szklarczyk-Smolana age 40 – President of the Management Board
Marcin Piechota age 45 – Vice President

Manner of representation

If the company has a one-person management board, it will be represented by one member (the President) of the management board, whereas if it has a multi-member management board, it will be represented as follows: A. by two members of the management board jointly; B. notwithstanding the foregoing provisions, if a member of the management board serving as Financial Director is appointed, the company will be represented by two members of the management board acting jointly, one of whom will be the member of the management board serving as Financial Director.

Supervisory board

Aleksander Kłósek age 45 – Supervisory Board Member
Dominik Herberholz age 47 – Supervisory Board Member
Michał Korostyński age 48 – Supervisory Board Member
Luiza Maria Nowacka-Samczuk age 35 – Supervisory Board Member
Magdalena Surowiec age 49 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2014-09-30.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
May 30, 2025Shareholders' meeting convened
Jun 3, 2024Shareholders' meeting convened
Jun 2, 2023Shareholders' meeting convened

Public aid

11 public aid cases recorded, with a total value of $3,418,000.

PurposeGross amount
Aid for SME access to finance — risk finance aid
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–

European Funds

4 projects co-financed from European Funds recorded, with total EU co-financing of $1,880,474.

ProjectEU co-financing
Development of a pharmacological genome interpretation system – PGx Plus
$869.3K
Promotion of Intelliseq genetic informatics products on the US market
$79,094
Development of an innovative technology for creating mobile applications for consumer genetics - MOBIGEN
$420.3K

Competitors

Name
Genxone S.A.
Precisionlife Poland sp. z o.o.
Camino Science sp. z o.o.
GMT Foodsafety sp. z o.o.
Nexbio sp. z o.o.
Ogólnopolska Grupa Badań Społecznych sp. z o.o.
Clinbit sp. z o.o.
Xenstats sp. z o.o.
Actn3 Bioinformatics sp. z o.o.
Data2biology sp. z o.o.

Change history

DateEvent
2025-11-28Share capital increase
2025-09-19Share capital increase
2025-05-19Share capital increase
2025-02-28Share capital increase
2022-12-30Share capital increase

FAQ

Last updated: 2026-10-03